Medical devices, healthcare technology and the business of care
PMA approval · P900033

INTEGRA DERMAL REGENERATION TEMPLATE

Integra Lifesciences Corp. · Decision date Mar 1, 1996

FDA DECISIONP900033

What did the FDA approve?

FDA records P900033 as an original PMA application. The recorded decision is approval, dated Mar 1, 1996.

FDA approval order statement

APPROVAL FOR THE INTEGRA ARTIFICAL SKIN
Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Mar 1, 1996

FDA source record

Regulatory record facts

Identifier
P900033
Regulatory pathway
Premarket approval application
Product code
MGR
Decision code
APPR
Decision date
Mar 1, 1996
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Dressing, wound and burn, interactive.

Product code
MGR
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P900033 received

    Application receipt date recorded by FDA.

  2. P900033 · FDA decision

    APPR

  3. P900033/S117 · Related supplement

    INTEGRA Dermal Regeneration Template, Integra Meshed Dermal Regeneration Template, and Integra Omnigraft Dermal Rege

Timeline entries are records held by MedtechLedger for P900033. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P900033

Product / regulatory recordCompanyPathwayDecision dateSource
Integra Lifesciences Corp.PMA supplementSep 18, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Integra Lifesciences Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
105 Morgan Ln., Plainsboro, NJ, 08536

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records